Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report

doi:10.12998/wjcc.v11.i6.1372

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2188)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

121

WORD

HTML

1164

Figures (1-3)

355

Sum=1685

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

182

Download

313

Sum=495

Feb 26, 2023 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 26, 2023; 11(6): 1372-1378
Published online Feb 26, 2023. doi: 10.12998/wjcc.v11.i6.1372

Full Size Figure Download Figure

Figure 1 A positron emission tomography scan with fluorodeoxyglucose F 18. A: Locoregional recurrence in August 2020; B: Partial response in May 2021.

Citation: Fabien MB, Elodie P, Anna S, Addeo P, Meher B. Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report. World J Clin Cases 2023; 11(6): 1372-1378
URL: https://www.wjgnet.com/2307-8960/full/v11/i6/1372.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i6.1372